Valneva SE [VALN] vs Vericel [VCEL] Detailed Stock Comparison
Valneva SE
NASDAQ
Loading...
Vericel
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Valneva SE wins in 7 metrics, Vericel wins in 11 metrics, with 0 ties. Vericel appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Valneva SE | Vericel | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 72.74 | 255.21 | Valneva SE |
| Price-to-Book Ratio | 10.84 | 5.87 | Vericel |
| Debt-to-Equity Ratio | 105.63 | 32.74 | Vericel |
| PEG Ratio | -21.68 | 74.44 | Valneva SE |
| EV/EBITDA | -61.51 | 190.23 | Valneva SE |
| Profit Margin (TTM) | -34.15% | 2.85% | Vericel |
| Operating Margin (TTM) | -22.01% | -3.21% | Vericel |
| Return on Equity | -38.02% | 2.59% | Vericel |
| Return on Assets (TTM) | -6.58% | 0.18% | Vericel |
| Free Cash Flow (TTM) | $-97.67M | $-5.81M | Vericel |
| 1-Year Return | 44.20% | -28.10% | Valneva SE |
| Price-to-Sales Ratio (TTM) | 5.26 | 7.24 | Valneva SE |
| Enterprise Value | $2.40B | $1.81B | Valneva SE |
| EV/Revenue Ratio | 10.47 | 7.26 | Vericel |
| Gross Profit Margin (TTM) | 50.10% | 73.71% | Vericel |
| Revenue per Share (TTM) | $2 | $5 | Vericel |
| Earnings per Share (Diluted) | $-1.08 | $0.14 | Vericel |
| Beta (Stock Volatility) | 1.00 | 1.27 | Valneva SE |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Valneva SE vs Vericel Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Valneva SE | -2.70% | 6.88% | 76.22% | 77.62% | 50.40% | 137.08% |
| Vericel | 0.23% | -0.92% | -0.06% | -13.71% | -31.85% | -35.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Valneva SE | 44.20% | -37.94% | -62.07% | -62.07% | -62.07% | -62.07% |
| Vericel | -28.10% | 30.92% | 116.49% | 1,017.98% | 26.57% | -92.06% |
Performance & Financial Health Analysis: Valneva SE vs Vericel
| Metric | VALN | VCEL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.03B | $1.80B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 126,110 | 456,322 |
| 90 Day Avg. Volume | 73,597 | 589,887 |
| Last Close | $11.19 | $35.44 |
| 52 Week Range | $3.62 - $12.25 | $33.09 - $63.00 |
| % from 52W High | -8.65% | -43.75% |
| All-Time High | $67.84 (Nov 29, 2021) | $1,590.00 (Sep 22, 1997) |
| % from All-Time High | -83.51% | -97.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.27% | 0.20% |
| Quarterly Earnings Growth | 0.48% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | -0.34% | 0.03% |
| Operating Margin (TTM) | -0.22% | -0.03% |
| Return on Equity (TTM) | -0.38% | 0.03% |
| Debt to Equity (MRQ) | 105.63 | 32.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.12 | $6.08 |
| Cash per Share (MRQ) | $0.97 | $2.32 |
| Operating Cash Flow (TTM) | $-13,893,130 | $47.24M |
| Levered Free Cash Flow (TTM) | $-40,138,450 | $-5,594,625 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Valneva SE vs Vericel
| Metric | VALN | VCEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 72.74 | 255.21 |
| Forward P/E | -21.68 | 74.44 |
| PEG Ratio | -21.68 | 74.44 |
| Price to Sales (TTM) | 5.26 | 7.24 |
| Price to Book (MRQ) | 10.84 | 5.87 |
| Market Capitalization | ||
| Market Capitalization | $1.03B | $1.80B |
| Enterprise Value | $2.40B | $1.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.47 | 7.26 |
| Enterprise to EBITDA | -61.51 | 190.23 |
| Risk & Other Metrics | ||
| Beta | 1.00 | 1.27 |
| Book Value per Share (MRQ) | $1.12 | $6.08 |
Financial Statements Comparison: Valneva SE vs Vericel
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VALN | VCEL |
|---|---|---|
| Revenue/Sales | $56.42M | $52.60M |
| Cost of Goods Sold | $28.16M | $16.33M |
| Gross Profit | $28.27M | $36.27M |
| Research & Development | $20.42M | $7.26M |
| Operating Income (EBIT) | $-12.42M | $-12.79M |
| EBITDA | $-11.78M | $-8.41M |
| Pre-Tax Income | $-13.79M | $-11.25M |
| Income Tax | $-260,350 | N/A |
| Net Income (Profit) | $-13.53M | $-11.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VALN | VCEL |
|---|---|---|
| Cash & Equivalents | $188.32M | $73.49M |
| Total Current Assets | $332.40M | $197.64M |
| Total Current Liabilities | $146.71M | $39.45M |
| Long-Term Debt | $173.09M | $87.80M |
| Total Shareholders Equity | $217.66M | $295.49M |
| Retained Earnings | $-682.69M | $-404.06M |
| Property, Plant & Equipment | $172.14M | $68.72M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VALN | VCEL |
|---|---|---|
| Operating Cash Flow | $-16.59M | $12.44M |
| Capital Expenditures | $-1.45M | N/A |
| Free Cash Flow | $-4.73M | $-7.61M |
| Debt Repayment | $-816,075 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VALN | VCEL |
|---|---|---|
| Shares Short | 45,532 | 5.56M |
| Short Ratio | 1.10 | 9.32 |
| Short % of Float | 0.00% | 0.14% |
| Average Daily Volume (10 Day) | 126,110 | 456,322 |
| Average Daily Volume (90 Day) | 73,597 | 589,887 |
| Shares Outstanding | 189.60M | 49.63M |
| Float Shares | 126.38M | 49.90M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.06% | 1.11% |
Dividend Analysis & Yield Comparison: Valneva SE vs Vericel
| Metric | VALN | VCEL |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |